PF-Atlas › Clinical Trials › NCT07447102

Phase II Clinical Study of BC006 in Patients With Idiopathic Pulmonary Fibrosis

BC006 · Phase 2

Registry ID

NCT07447102

Phase

Phase 2

Status

Recruiting

Drug / intervention

BC006

Sponsor

Dragonboat Biopharmaceutical Company Limited

Start

2026-04-27

About this trial

BC006 is evaluated in NCT07447102, a Phase 2 idiopathic pulmonary fibrosis study sponsored by Dragonboat Biopharmaceutical Company Limited. Current status: Recruiting.

View NCT07447102 on ClinicalTrials.gov →

Explore related

All BC006 trials All IPF trials

Medical disclaimer. This page summarizes public trial data for NCT07447102 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.